Postdoc in patient-derived pre-cancer organoids and gastric cancer therapy optimization Vanderbilt University in United States

CHOI LAB at Vanderbilt University is hiring a postdoc to work on patient-derived pre-cancer organoids and translational research aimed at reducing the risk of gastric cancer.

The project focuses on examining the susceptibility of pre-cancerous lesions to drug treatment and optimizing possible therapies using Pyrvinium in the context of a Phase II trial. The lab’s broader research interests include gastric carcinogenesis, stem cells, transgenic mouse models, and organoid models.

This is a research-intensive postdoctoral opening suited to candidates with a strong background or interest in organoid biology, cancer biology, and translational therapeutic studies. Experience with patient-derived models, stem cell systems, and drug-response experiments would be especially relevant.

No deadline, funding package, or formal application portal was stated in the post. Interested candidates should use the lab’s X profile and Vanderbilt lab page to identify contact details and application instructions.